FFCP PHASE2:Hg19::chr1:173640358..173640371,+
From FANTOM5_SSTAR
Revision as of 00:32, 28 July 2015 by Autoedit (talk | contribs) (Created page with "{{FFCP |DHSsupport=supported |DPIdataset=robust |EntrezGene=NA |GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript |HGNC=NA |TSSclassifier=stron...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Short description: | p@chr1:173640358..173640371, + |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr1:173640358..173640371, + |
Coexpression cluster: | C132_acute_small_Dendritic_Macrophage_CD14_Neutrophils_Monocytederived |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p@chr1:173640358..173640371+ |
---|
0
1
2
3
4
5
6
7
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
monopoietic cell | 2.45e-08 | 59 |
monocyte | 2.45e-08 | 59 |
monoblast | 2.45e-08 | 59 |
promonocyte | 2.45e-08 | 59 |
myeloid cell | 4.22e-08 | 108 |
common myeloid progenitor | 4.22e-08 | 108 |
macrophage dendritic cell progenitor | 4.28e-08 | 61 |
myeloid lineage restricted progenitor cell | 1.49e-07 | 66 |
granulocyte monocyte progenitor cell | 1.88e-07 | 67 |
myeloid leukocyte | 5.36e-07 | 72 |
Showing 1 to 10 of 10 entries
Ontology term | p-value | n |
---|---|---|
myeloid leukemia | 2.93e-26 | 31 |
leukemia | 4.38e-21 | 39 |
hematologic cancer | 2.36e-16 | 51 |
immune system cancer | 2.36e-16 | 51 |
Showing 1 to 4 of 4 entries